These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31782500)

  • 1. From peer-based to peer-led: redefining the role of peers across the hepatitis C care pathway: HepCare Europe.
    Surey J; Menezes D; Francis M; Gibbons J; Sultan B; Miah A; Abubakar I; Story A
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v17-v23. PubMed ID: 31782500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.
    Barror S; Avramovic G; Oprea C; Surey J; Story A; Macías J; Cullen W; Crowley D; Horan A; Naughton AM; Iglesias M; Ianache I; Lazar S; Popa I; McHugh T; Menezes D; Tinago W; Lambert JS
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v39-v46. PubMed ID: 31782499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring and understanding HCV patient journeys- HEPCARE Europe project.
    Glaspy S; Avramovic G; McHugh T; Oprea C; Surey J; Ianache I; Macías J; Story A; Cullen W; Lambert JS
    BMC Infect Dis; 2021 Mar; 21(1):239. PubMed ID: 33673828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
    Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
    Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HepCare Europe-A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA.
    Avramovic G; Oprea C; Surey J; Story A; Macías J; Cullen W; Iglesias M; Mc Hugh T; Crowley D; Naughton AM; Horan A; Ianache I; Lazar S; Popa I; Menezes D; Lambert JS
    Int J Infect Dis; 2020 Feb; 91():246-251. PubMed ID: 31785401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'HepCheck Dublin': an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care.
    Lambert JS; Murtagh R; Menezes D; O'Carroll A; Murphy C; Cullen W; McHugh T; Avramovic G; Tinago W; Van Hout MC
    BMC Infect Dis; 2019 Feb; 19(1):128. PubMed ID: 30732573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.
    Crowley D; Murtagh R; Cullen W; Keevans M; Laird E; McHugh T; McKiernan S; Miggin SJ; O'Connor E; O'Reilly D; Betts-Symonds G; Tobin C; Van Hout MC; Lambert JS
    Harm Reduct J; 2019 Jul; 16(1):42. PubMed ID: 31277665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
    Grebely J; Gilliver R; McNaughton T; Conway A; Cunningham E; Henderson C; Hadlow B; Molloy K; Doab A; Tillakeratne S; Pepolim L; Harrod ME; Dore GJ; Read P
    Int J Drug Policy; 2023 Apr; 114():103982. PubMed ID: 36863287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK.
    Ward Z; Campbell L; Surey J; Platts S; Glass R; Hickman M; Story A; Vickerman P
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v5-v16. PubMed ID: 31782503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practising critical resilience as an advanced peer support worker in London: A qualitative evaluation of a peer-led hepatitis C intervention amongst people experiencing homelessness who inject drugs.
    Surey J; Francis M; Gibbons J; Leonard M; Abubakar I; Story A; MacLellan J
    Int J Drug Policy; 2021 May; 91():103089. PubMed ID: 33460981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
    Grebely J; Knight E; Genoway KA; Viljoen M; Khara M; Elliott D; Gallagher L; Storms M; Raffa JD; DeVlaming S; Duncan F; Conway B
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):270-7. PubMed ID: 20425880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention.
    Stagg HR; Surey J; Francis M; MacLellan J; Foster GR; Charlett A; Abubakar I
    BMC Med; 2019 Apr; 17(1):71. PubMed ID: 30929642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.
    Crawford S; Bath N
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S75-9. PubMed ID: 23884070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer support in small towns: A decentralized mobile Hepatitis C virus clinic for people who inject drugs.
    Midgard H; Bjørnestad R; Egeland M; Dahl E; Finbråten AK; Kielland KB; Blindheim M; Dalgard O
    Liver Int; 2022 Jun; 42(6):1268-1277. PubMed ID: 35362660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.
    Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J;
    Int J Drug Policy; 2022 Jul; 105():103706. PubMed ID: 35533635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
    Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
    Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
    Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
    Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.